- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07487974
Active Oxygen and Negative Ion Sanitary Pads for Episiotomy Pain, Healing, and Postpartum Symptoms
Effects of Active Oxygen and Negative Ion Sanitary Pads on Episiotomy Pain, Healing, and Postpartum Physical Symptom Severity in Primiparous Women: A Randomized Controlled Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Episiotomy is a surgical incision made during vaginal birth to enlarge the vaginal opening and support delivery. Although it can help prevent complications during childbirth, many women experience pain, discomfort, difficulty sitting, and delayed wound healing after the procedure. In the postpartum period, appropriate hygiene and wound care are essential to reduce discomfort, prevent infection, and support the healing of the perineal area. The tissues around the vulva and vagina become more sensitive due to increased moisture and hormonal changes, making the choice of hygiene products particularly important.
Sanitary pads containing active oxygen and negative ions have recently been introduced as a new type of hygiene product. These components are believed to improve comfort, support wound healing, and reduce irritation. Although their clinical effects in the postpartum period have not yet been extensively studied, their potential benefits make them a promising option for women recovering from episiotomy.
This study aims to examine whether sanitary pads with active oxygen and negative ions can reduce episiotomy pain, support wound healing, and decrease postpartum physical symptoms in primiparous women. Participants will be randomly assigned to either the intervention group using these special pads or the control group using standard postpartum pads. The findings may contribute to determining whether these products offer additional advantages in the early postpartum recovery process.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Karaman, Turkey (Türkiye)
- Eğitim ve Araştırma Hastanesi
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Women aged 18 years or older
- At least primary school education
- Gestational age between 37 and 42 weeks
- Single, live, vaginal birth
- Mediolateral episiotomy performed
- Hemoglobin level > 11 mg/dL
- Voluntary participation and ability to provide informed consent
Exclusion Criteria:
- History of high-risk pregnancy
- History of high-risk or complicated labor
- Use of operative vaginal delivery methods (forceps, vacuum, etc.)
- Presence of additional perineal lacerations, including 3rd-degree tears or anal sphincter injury
- Cephalopelvic disproportion
- Postpartum hemorrhage
- Newborn requiring NICU care
- Diagnosis of vaginal fungal infection or sexually transmitted infections (e.g., herpes simplex, HPV)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Control Group
Participants in this group will use standard postpartum sanitary pads during the early postpartum period following episiotomy.
All participants will also receive routine postpartum care.
|
Participants in the control group will use standard postpartum sanitary pads following episiotomy.
Routine postpartum care will be provided to all participants.
The control product does not contain active oxygen or negative ions.
|
|
Experimental: Pad Group
Participants in this group will use sanitary pads containing active oxygen and negative ions during the early postpartum period following episiotomy.
All participants will also receive routine postpartum care.
|
Participants in the intervention group will use sanitary pads containing active oxygen and negative ions during the early postpartum period following episiotomy.
The product is applied as a hygiene pad and is not classified as a drug or medical device.
Routine postpartum care will be provided to all participants.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Episiotomy Pain Score
Time Frame: Measurements will be conducted at: • 24 hours postpartum • 3rd day postpartum • 7th day postpartum
|
Episiotomy-related pain will be assessed using a 10-point Visual Analog Scale (VAS), ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst possible pain.
|
Measurements will be conducted at: • 24 hours postpartum • 3rd day postpartum • 7th day postpartum
|
|
Episiotomy Wound Healing Score
Time Frame: Measurement Times: 24 hours after birth 3rd day postpartum 7rd day postpartum
|
Wound healing will be evaluated using the REEDA Scale (Redness, Edema, Ecchymosis, Discharge, Approximation). Each item is scored from 0 to 3, with a total score ranging from 0 to 15. Higher scores indicate poorer wound healing (greater tissue trauma). |
Measurement Times: 24 hours after birth 3rd day postpartum 7rd day postpartum
|
|
Postpartum Physical Symptom Severity
Time Frame: Measurement Times: 24 hours after birth 3rd day postpartum 7rd day postpartum
|
Postpartum physical symptom severity will be measured using the Postpartum Physical Symptom Severity Scale. The scale consists of 18 items, each rated on a 4-point Likert scale (0 = none, 1 = mild, 2 = moderate, 3 = severe), with total scores ranging from 0 to 54. Higher scores indicate greater severity of postpartum physical symptoms. |
Measurement Times: 24 hours after birth 3rd day postpartum 7rd day postpartum
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- KTO-EPIZYO-RCT-2025
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Episiotomy
-
Universidad PanamericanaUniversidad de la Salud - UNISA; IMSS-Bienestar; Secretaría de Educación, Ciencia...Not yet recruitingEpisiotomy | Episiotomy Wound | Episiotomy Extended by Laceration | Episiotomy Infection
-
Alaa Nadhim HameedCompletedEpisiotomy Wound | Normal Vaginal Delivery | Episiotomy Infection | Surgical Site Infection PreventionIraq
-
Ain Shams UniversityLobna Ahmed Nabil; Dr. Ahmed Sherif; Dr. Mohamed Mahmoud El Sherbiny; Prof. Mohamed... and other collaboratorsCompletedEpisiotomy
-
Sharon Davidesko MDRecruitingEpisiotomy; Complications | Episiotomy Extended by Laceration | Episiotomy InfectionIsrael
-
Muhammad Aamir LatifCompletedEpisiotomy WoundPakistan
-
Ayşegül KanıkRecruiting
-
Ain Shams UniversityUnknown
-
Aesculap AGB.Braun Surgical SACompleted
-
Ain Shams UniversityUnknown
-
Instituto Materno Infantil Prof. Fernando FigueiraCompletedNeed of EpisiotomyBrazil
Clinical Trials on Active Oxygen and Negative Ion Sanitary Pad
-
New York State Psychiatric InstituteNational Institute of Mental Health (NIMH)CompletedDepression | Mood Disorders | Depressive Disorders | Chronic DepressionUnited States
-
University of British ColumbiaCentre for Addiction and Mental Health; Canadian Institutes of Health Research... and other collaboratorsRecruitingMajor Depressive Disorder, Recurrent, in RemissionCanada
-
University of OxfordMedical Research Council; P1vital Products LimitedCompletedEmotion | Bright Light Treatment | Facial Expression RecognitionUnited Kingdom
-
University of MauritiusAcelity; Ministry of Health and Wellness, Mauritius; Higher Education Commission...Completed
-
VA Office of Research and DevelopmentRecruitingObstructive Sleep Apnea | OSA COPD Overlap SyndromeUnited States
-
Becton, Dickinson and CompanyCompleted
-
University Hospital, Basel, SwitzerlandSwiss National Science FoundationCompletedUrinary Tract Infections | Upper Respiratory Tract InfectionsSwitzerland
-
University of OklahomaCenters for Disease Control and PreventionCompletedFetal Alcohol Spectrum Disorders | Fetal Alcohol Syndrome (FAS) | Alcohol Related Neurodevelopmental Disorder | Alcohol Use Complicating Pregnancy, Unspecified TrimesterUnited States, Russian Federation
-
Alexandria UniversityRecruitingStage III PeriodontitisEgypt
-
SCARE (Study group for carbapenem resistance)Unknown